Global Chronic Disease Management Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2031

Chronic Disease Management Market Analysis  

The chronic disease management (CDM) market is experiencing significant growth, driven by the rising prevalence of chronic illnesses such as diabetes, cardiovascular diseases, and respiratory disorders. Advances in technology, particularly the integration of telehealth and mobile health applications, have transformed how healthcare providers deliver care, making it more accessible and efficient. In recent years, several key developments have emerged, such as the launch of AI-driven platforms that enhance patient monitoring and data analytics, allowing for personalized care plans tailored to individual patient needs. For instance, WellSky's predictive analytics capabilities within its CarePort Connect solution facilitate timely referrals for hospice care, showcasing the potential of data-driven approaches in CDM. In addition, partnerships between healthcare organizations and tech companies, like the collaboration between Premier, Inc. and AstraZeneca, aim to improve awareness and management of chronic kidney disease, further illustrating the market's focus on comprehensive care strategies. Overall, the CDM market is poised for growth, supported by innovative solutions and an increasing emphasis on proactive healthcare management to improve patient outcomes and reduce healthcare costs.

Chronic Disease Management Market Size

The global chronic disease management market size was valued at USD 7.17 billion in 2023 and is projected to reach USD 24.01 billion by 2031, with a CAGR of  16.30% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Chronic Disease Management Market Trends

“Increasing Adoption of Digital Health Technologies”

The chronic disease management (CDM) market is experiencing significant growth, propelled by partnerships between healthcare organizations and tech companies. One prominent trend in the chronic disease management (CDM) market is the increasing adoption of digital health technologies, particularly telehealth and remote patient monitoring solutions. These technologies enhance patient engagement and empower individuals to take control of their health through continuous monitoring and timely interventions. For instance, companies such as WellSky are incorporating advanced predictive analytics into their CDM platforms, enabling healthcare providers to identify patients at risk of complications and facilitating early interventions. This shift towards digital solutions improves patient outcomes and  streamlines care coordination, reducing the burden on healthcare systems. Furthermore, as more patients prefer virtual consultations and remote monitoring, healthcare organizations are investing in user-friendly mobile applications that allow for real-time communication between patients and providers. This trend reflects the ongoing transformation of the CDM landscape, making chronic disease management more efficient and accessible while enhancing overall healthcare delivery.

Report Scope and Chronic Disease Management Market Segmentation         

Chronic Disease Management Market Definition

Chronic disease management refers to the coordinated, long-term care and support provided to individuals with chronic illnesses to help them manage their conditions effectively. Chronic diseases, such as diabetes, hypertension, heart disease, and asthma, often require continuous monitoring, medication adherence, lifestyle changes, and regular healthcare interventions. The goal of chronic disease management is to improve the patient's quality of life, reduce complications, prevent disease progression, and minimize the need for hospitalizations or emergency care through personalized treatment plans, education, and self-care strategies.

Chronic Disease Management Market Dynamics

Drivers

• Increasing Prevalence of Chronic Diseases

The rising prevalence of chronic diseases globally has significantly boosted the demand for CDM services and solutions. For instance, the World Health Organization reported that chronic diseases are responsible for 71% of all deaths globally, emphasizing the need for effective management strategies. CDM aids in medication adherence and enhances overall patient care by providing tailored resources, educational materials, and support systems. Such holistic approach helps individuals better understand their conditions, leading to improved self-management and health outcomes. Consequently, as the incidence rates of chronic diseases continue to rise, the demand for comprehensive CDM solutions is anticipated to grow, driving market expansion and innovation in healthcare delivery systems.

• Growing Geriatric Population

Aging is a significant risk factor for numerous chronic diseases, making the geriatric population a critical demographic in healthcare. Older adults typically require more medical services compared to younger adults, as they often suffer from a range of chronic health issues, including diabetes, hypertension, and heart disease. For instance, according to the Centers for Disease Control and Prevention (CDC), about 80% of older adults have at least one chronic condition, and 68% have two or more. Such high prevalence positions older adults as the primary users of Chronic Disease Management (CDM) services and solutions, which are tailored to address their unique healthcare needs. As the global geriatric population continues to grow expected to reach approximately 1.5 billion by 2050 the demand for effective CDM services is anticipated to escalate. This trend underscores the importance of developing specialized solutions for this demographic and drives significant market growth as healthcare systems adapt to meet the increasing needs of aging individuals.

Opportunities

• Surge in Novel Technological Advancements

Chronic diseases have emerged as one of the leading causes of death in emerging economies and developing countries, prompting a heightened focus on chronic disease management (CDM) among public health practitioners. For instance, according to the World Health Organization (WHO), chronic diseases account for nearly 60% of deaths in low- and middle-income countries. The integration of advanced technologies has revolutionized the management of chronic conditions such as asthma, arthritis, and diabetes, ensuring that patients are no longer treated in isolation. Innovative healthcare monitoring applications and devices, such as wearable fitness trackers and mobile health apps, have significantly improved communication between patients and healthcare providers. These tools facilitate real-time updates to treatment plans, leading to better health outcomes.  Such technological evolution creates a substantial opportunity for market growth, as healthcare systems increasingly adopt CDM solutions to enhance patient care and overall health outcomes in managing chronic diseases.

• Rising Healthcare Expenditure

Rising healthcare expenditure globally presents a significant opportunity for the chronic disease management (CDM) market, as governments and private sectors allocate more funds toward improving healthcare services and technologies. According to the World Bank, global health expenditure reached approximately 9.8% of the world's GDP in 2020, reflecting a growing commitment to health infrastructure and services. Increased spending on healthcare often translates to enhanced funding for CDM solutions that facilitate better management of chronic diseases. For instance, the introduction of innovative telehealth platforms allows healthcare providers to monitor patients remotely, reducing hospital visits and improving access to care. As healthcare budgets continue to expand, investments in CDM technologies are likely to rise, fostering a more robust market environment focused on enhancing patient outcomes and managing chronic illnesses effectively.

Restraints/Challenges

• Data Privacy and Security Concerns

Data privacy and security concerns pose significant challenges for the chronic disease management (CDM) market, particularly with the growing reliance on digital tools and telehealth platforms. As healthcare providers adopt these technologies to enhance patient care, the risk of data breaches and unauthorized access to sensitive patient information also escalates. For instance, a 2021 survey revealed that  in 2021, over 45 million patient medical records were affected by cyber threats, which was a significant increase from 2020. Compliance with regulations like the Health Insurance Portability and Accountability Act (HIPAA) adds another layer of complexity, as healthcare organizations must implement stringent security measures to protect patient data. Failure to adhere to these regulations can result in substantial fines and legal liabilities, deterring healthcare providers from fully embracing digital solutions for chronic disease management.

• High Costs of Implementation

High costs of implementation pose a significant challenge for establishing chronic disease management (CDM) programs, particularly for smaller healthcare providers with limited financial resources. The initial investment required for technology solutions, such as electronic health record (EHR) systems, telehealth platforms, and data analytics tools, can be substantial. For instance, a small clinic may face considerable startup expenses to integrate a comprehensive CDM solution, which includes purchasing software, training staff, and maintaining the system. In addition, ongoing operational costs, such as hiring specialized personnel and ensuring compliance with evolving regulations, further strain budgets. This financial burden can deter smaller healthcare organizations from adopting CDM programs, limiting access to vital services for patients with chronic conditions. Consequently, the high costs associated with implementing CDM initiatives can hinder overall market growth and patient care improvements

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Chronic Disease Management Market Scope

The market is segmented on the basis of type, disease indication, deployment types and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Solution
  • On-Premise Solution
  • Cloud-Based Solution
  • Web-Based
• Services
  • Educational Service
  • Implementation Service
  • Consulting Service
  • Others

Disease Indication

• Cardiovascular Diseases (CVD)
• Diabetes
• Chronic Obstructive Pulmonary Disorders (COPD)
• Arthritis
• Asthma
• Cancer
• Others

Deployment Types

• On-Premises
• Cloud-Based
• Web-Based

End User

• Healthcare Providers
• Healthcare Payers
• Others

Chronic Disease Management Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, type, disease indication, deployment types, and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is poised to lead the global chronic disease management market, primarily driven by the rising elderly population that requires ongoing care and support for chronic conditions. The region's strong emphasis on technological advancements, such as telehealth and digital health tools, further enhances the effectiveness of chronic disease management strategies. In addition, the presence of key market players and their continuous innovation are expected to significantly boost the growth rate of the market in North America.

Asia-Pacific region is anticipated to experience significant growth in the chronic disease management (CDM) market from 2024 to 2031, driven by the rising availability of CDM providers that offer essential services to manage various chronic conditions. This growth is further supported by increasing healthcare investments and the implementation of policies aimed at enhancing access to healthcare facilities. Moreover, the region's expanding population and the growing prevalence of chronic diseases are likely to create a greater demand for effective CDM solutions, thereby contributing to the market's expansion.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Chronic Disease Management Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Chronic Disease Management Market Leaders Operating in the Market Are:

• WellSky (U.S.)
• ZeOmega (India)
• Health Catalyst (U.S.)
• Cedar Gate Technologies (U.S.)
• Cognizant (U.S.)
• Pegasystems Inc. (U.S.)
• Epic Systems Corporation (U.S.)
• Hinduja Global Solutions Ltd. (India)
• NXGN Management, LLC (U.S.)
• MINES & Associates, Inc. (U.S.)
• Zyter (U.S.)
• ExlServings Holdings, Inc. (U.S.)
• cliexa, Inc. (U.S.)
• ScienceSoft USA Corporation (U.S.)
• Optum, Inc. (U.S.)
• Veradigm LLC (U.S.)
• Infosys Limited (India)
• Medecision (U.S.)
• IBM (U.S.)
• Health Plan Alliance (U.S.)
• TATA Consultancy Services Limited (India)

Latest Developments in Chronic Disease Management Market

• In May 2023, WellSky, a prominent technology company in health and community care, has unveiled new predictive analytics features in its CarePort Connect solution. These enhancements aim to assist hospitals, payers, and post-acute care providers in more effectively identifying patients who are appropriate for hospice care and facilitating timely referrals. With a referral network encompassing 2,000 hospitals across the U.S., WellSky facilitates over 13 million hospital discharges annually and is now launching a groundbreaking national hospice suitability identification network
• In May 2024, Premier, Inc. is pleased to announce a strategic partnership with AstraZeneca for the Uncover CKD - Care Collective initiative. This collaboration aims to identify patients with undiagnosed clinical chronic kidney disease (CKD), enhance awareness of undiagnosed CKD among healthcare providers, and guide U.S. health systems looking to improve or establish strategies for the diagnosis, treatment, and management of CKD
• In Januray 2024, Eli Lilly and Company has announced the launch of LillyDirect, a new digital healthcare platform designed for patients in the U.S. dealing with obesity, migraine, and diabetes. LillyDirect provides disease management resources, including access to independent healthcare providers, personalized support, and the direct home delivery of select Lilly medications via third-party pharmacy dispensing services
• In November 2021, IBM introduced Imaging AI Orchestration, a groundbreaking solution designed to enable imaging organizations to harness the full potential of artificial intelligence applications in a cohesive manner. This platform allows for the seamless integration of various AI tools, enhancing workflow efficiency and improving diagnostic accuracy in medical imaging
• In April 2021, WellSky introduced an advanced management solution for home health visits called CareInsights Guidance. This innovative component provides actionable insights on visit utilization, aimed at optimizing treatment quality and enhancing patient health outcomes. The launch of this solution is anticipated to benefit both patients and employees while driving the company's sales growth

SKU-39216